HomeELTX • NASDAQ
add
Elicio Therapeutics Inc
Previous close
$7.46
Day range
$7.63 - $8.06
Year range
$3.34 - $9.98
Market cap
125.26M USD
Avg Volume
41.04K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.74M | 4.83% |
Net income | -11.21M | 5.23% |
Net profit margin | — | — |
Earnings per share | -0.87 | 24.35% |
EBITDA | -10.68M | -5.16% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.35M | 54.82% |
Total assets | 28.14M | 14.97% |
Total liabilities | 19.24M | -1.89% |
Total equity | 8.90M | — |
Shares outstanding | 15.98M | — |
Price to book | 13.32 | — |
Return on assets | -95.31% | — |
Return on capital | -182.44% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -11.21M | 5.23% |
Cash from operations | -10.12M | 16.52% |
Cash from investing | — | — |
Cash from financing | 10.33M | -6.31% |
Net change in cash | 240.00K | 121.92% |
Free cash flow | -5.67M | 32.57% |
About
Founded
2011
Headquarters
Website
Employees
32
